Financials Allegra Medical Technologies Limited
Equities
AMT
AU000000AMT8
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 AUD | +26.09% | -.--% | -35.56% |
Mar. 22 | Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Mar. 11 | Trading in Allegra Medical Technologies' Stock Could Resume on March. 25 | MT |
Valuation
Fiscal Period: Junio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 10.45 | 8.96 | 8.861 | 20.89 | 18.8 | 5.745 |
Enterprise Value (EV) 1 | 8.839 | 7.968 | 8.272 | 20.88 | 20.93 | 8.871 |
P/E ratio | -16.4 x | -10.7 x | -7.6 x | -36.1 x | -7.41 x | -1.57 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.99 x | 1.75 x | 1.43 x | 3.32 x | 4.79 x | 8.31 x |
EV / Revenue | 1.69 x | 1.56 x | 1.33 x | 3.31 x | 5.33 x | 12.8 x |
EV / EBITDA | -34.2 x | -13.9 x | -9.52 x | -80.7 x | -10.4 x | -5.85 x |
EV / FCF | -3.72 x | -28.7 x | 21.4 x | -74.3 x | -22 x | 6.94 x |
FCF Yield | -26.9% | -3.48% | 4.67% | -1.35% | -4.54% | 14.4% |
Price to Book | 1.61 x | 1.58 x | 1.95 x | 4.57 x | 8.82 x | -3.83 x |
Nbr of stocks (in thousands) | 99,559 | 99,559 | 99,559 | 104,459 | 104,459 | 104,459 |
Reference price 2 | 0.1050 | 0.0900 | 0.0890 | 0.2000 | 0.1800 | 0.0550 |
Announcement Date | 8/23/18 | 8/30/19 | 8/27/20 | 8/26/21 | 8/26/22 | 8/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Junio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 5.243 | 5.12 | 6.201 | 6.301 | 3.929 | 0.6913 |
EBITDA 1 | -0.2585 | -0.5747 | -0.8686 | -0.2587 | -2.021 | -1.516 |
EBIT 1 | -0.5962 | -0.8408 | -1.157 | -0.5662 | -2.401 | -1.785 |
Operating Margin | -11.37% | -16.42% | -18.66% | -8.98% | -61.11% | -258.27% |
Earnings before Tax (EBT) 1 | -0.6041 | -0.8355 | -1.165 | -0.5788 | -2.535 | -2.086 |
Net income 1 | -0.6041 | -0.8355 | -1.165 | -0.5788 | -2.535 | -3.648 |
Net margin | -11.52% | -16.32% | -18.79% | -9.19% | -64.53% | -527.67% |
EPS 2 | -0.006410 | -0.008399 | -0.0117 | -0.005545 | -0.0243 | -0.0349 |
Free Cash Flow 1 | -2.374 | -0.2777 | 0.3861 | -0.2811 | -0.95 | 1.278 |
FCF margin | -45.27% | -5.42% | 6.23% | -4.46% | -24.18% | 184.91% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/23/18 | 8/30/19 | 8/27/20 | 8/26/21 | 8/26/22 | 8/31/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 2.13 | 3.13 |
Net Cash position 1 | 1.61 | 0.99 | 0.59 | 0.01 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -1.052 x | -2.062 x |
Free Cash Flow 1 | -2.37 | -0.28 | 0.39 | -0.28 | -0.95 | 1.28 |
ROE (net income / shareholders' equity) | -10.9% | -13.8% | -22.8% | -12.7% | -75.6% | -659% |
ROA (Net income/ Total Assets) | -5.78% | -7.39% | -10.6% | -5.37% | -25.1% | -26.2% |
Assets 1 | 10.46 | 11.31 | 10.99 | 10.78 | 10.09 | 13.93 |
Book Value Per Share 2 | 0.0700 | 0.0600 | 0.0500 | 0.0400 | 0.0200 | -0.0100 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0100 | 0 | 0 | 0 |
Capex 1 | 0.96 | 0.03 | 0.14 | 0.03 | 0.09 | 0.02 |
Capex / Sales | 18.34% | 0.68% | 2.27% | 0.49% | 2.33% | 2.66% |
Announcement Date | 8/23/18 | 8/30/19 | 8/27/20 | 8/26/21 | 8/26/22 | 8/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 2.26M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- AMT Stock
- Financials Allegra Medical Technologies Limited